StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
243
This month
1
This week
1
This year
15
Today
1
Yesterday
1
Publishing Date
2024 - 03 - 05
2
2023 - 11 - 07
2
2023 - 11 - 02
3
2023 - 10 - 25
2
2023 - 09 - 13
2
2023 - 08 - 03
3
2023 - 04 - 26
2
2023 - 02 - 23
2
2023 - 02 - 21
2
2022 - 12 - 08
2
2022 - 09 - 15
2
2022 - 09 - 13
2
2022 - 08 - 11
2
2022 - 07 - 27
2
2022 - 01 - 21
2
2021 - 12 - 22
2
2021 - 12 - 14
2
2021 - 11 - 12
3
2021 - 11 - 05
2
2021 - 10 - 28
2
2021 - 10 - 15
2
2021 - 09 - 29
2
2021 - 09 - 28
2
2021 - 09 - 07
2
2021 - 08 - 09
2
2021 - 07 - 29
2
2021 - 07 - 21
2
2021 - 06 - 30
2
2021 - 06 - 23
2
2021 - 06 - 07
2
2021 - 05 - 15
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 05 - 03
2
2021 - 04 - 29
1
2021 - 04 - 27
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 21
1
2021 - 04 - 19
2
2021 - 04 - 16
1
2021 - 04 - 15
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 04 - 09
1
2021 - 04 - 08
2
2021 - 04 - 07
1
2021 - 04 - 06
1
2021 - 03 - 31
1
2021 - 03 - 29
1
2021 - 03 - 24
1
2021 - 03 - 23
1
2021 - 03 - 11
2
2021 - 01 - 28
1
2021 - 01 - 07
1
2020 - 12 - 21
1
2020 - 12 - 08
2
2020 - 12 - 03
1
Sector
Commercial services
3
Consumer non-durables
1
Finance
2
Health technology
243
Manufacturing
3
N/a
1
Professional, scientific, and technical services
3
Tags
Alcohol use disorder
3
Alzheimer’s
5
Application
12
Approval
13
Biotech
7
Biotech-bay
7
Cancer
10
Chronic hepatitis b
4
Clinical-trials-phase-i
6
Clinical-trials-phase-ii
4
Clinical-trials-phase-iii
14
Collaboration
4
Conference
19
Day
5
Disease
13
Drug
11
Earnings
21
Europe
5
Events
26
Fda
9
Financial
21
Financial results
13
Food
5
Genetown
37
Global
4
Growth
5
Hepatitis
19
Hypertension
5
Iot
7
Kidney
4
Leo
4
Liver
16
Market
10
Media
4
Meeting
6
N/a
80
New drug
4
Ongoing
5
People
9
Pharma
4
Pharmaceuticals
6
Phase 1
7
Phase 2
11
Phase 3
23
Positive
19
Potential
4
Presentation
12
Program
6
Report
10
Research
19
Results
79
Study
12
Technology
12
Therapeutics
9
Topline
7
Treatment
38
Trial
12
Update
6
Vir-2218
4
Year
7
Entities
89bio, inc.
2
Abbott laboratories
2
Abbvie inc.
12
Abeona therapeutics inc.
2
Acadia pharmaceuticals inc.
4
Adaptimmune therapeutics plc
3
Adc therapeutics sa
5
Agios pharmaceuticals, inc.
12
Alkermes plc
4
Alnylam pharmaceuticals, inc.
243
Altimmune, inc.
2
Amgen inc.
11
Applied genetic technologies corporation
2
Arrowhead pharmaceuticals, inc.
2
Astellas pharma inc
2
Aveo pharmaceuticals, inc.
10
Axcella health inc.
2
Beigene, ltd.
10
Biogen inc.
5
Biontech se
2
Bluebird bio, inc.
3
Blueprint medicines corporation
14
Bristol-myers squibb company
11
Clovis oncology, inc.
10
Crispr therapeutics ag
2
Danaher corporation
3
Editas medicine, inc.
4
Eli lilly and company
38
Epizyme, inc.
11
Exelixis, inc.
14
Gilead sciences, inc.
6
Illumina, inc.
10
Incyte corporation
14
Intellia therapeutics, inc.
4
Ionis pharmaceuticals, inc.
11
Ironwood pharmaceuticals, inc.
4
Jazz pharmaceuticals plc
4
Johnson & johnson
8
Karyopharm therapeutics inc.
10
Madrigal pharmaceuticals, inc.
3
Moderna, inc.
6
Neurocrine biosciences, inc.
4
Novartis ag
5
Novo nordisk a/s
25
Pfizer, inc.
14
Ptc therapeutics, inc.
4
Regeneron pharmaceuticals, inc.
24
Rigel pharmaceuticals, inc.
10
Royalty pharma plc
3
Sage therapeutics, inc.
4
Sangamo therapeutics, inc.
4
Sanofi
78
Sarepta therapeutics, inc.
8
Teva pharmaceutical industries ltd
4
Ultragenyx pharmaceutical inc.
5
United therapeutics corporation
4
Verastem, inc.
10
Vir biotechnology, inc.
24
Xencor, inc.
4
Y-mabs therapeutics, inc.
10
Symbols
AAPL
1197
ABB
1426
ABBV
1024
ABLZF
1165
ABT
1786
ACN
600
AMGN
742
ARVL
4293
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7187
FRBA
598
GE
915
GLAXF
657
GOOG
1279
GOOGL
1278
GSK
883
HON
1784
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4575
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4283
MSFT
1200
MT
589
NOC
589
NOK
900
NOKBF
974
NVO
631
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1476
SAPGF
1230
SNOW
796
SNY
4534
SNYNF
3592
TEVJF
631
TMO
1622
VZ
1213
XYF
676
Exchanges
Amex
1
Nasdaq
243
Nyse
60
Crawled Date
2024 - 03 - 05
2
2023 - 11 - 07
2
2023 - 11 - 03
2
2023 - 11 - 02
2
2023 - 10 - 25
2
2023 - 09 - 13
2
2023 - 08 - 03
3
2023 - 04 - 26
2
2023 - 02 - 23
2
2023 - 02 - 21
2
2022 - 12 - 08
2
2022 - 09 - 15
2
2022 - 09 - 13
2
2022 - 08 - 11
2
2022 - 07 - 27
2
2022 - 01 - 21
2
2021 - 12 - 22
2
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 05
2
2021 - 10 - 28
2
2021 - 10 - 15
2
2021 - 09 - 29
2
2021 - 09 - 28
2
2021 - 09 - 07
2
2021 - 08 - 09
2
2021 - 07 - 21
2
2021 - 06 - 30
2
2021 - 06 - 23
2
2021 - 06 - 07
2
2021 - 05 - 15
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 05 - 03
2
2021 - 04 - 29
1
2021 - 04 - 27
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 21
1
2021 - 04 - 19
2
2021 - 04 - 16
1
2021 - 04 - 15
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 04 - 09
1
2021 - 04 - 08
2
2021 - 04 - 07
1
2021 - 04 - 06
1
2021 - 03 - 31
1
2021 - 03 - 29
1
2021 - 03 - 24
1
2021 - 03 - 23
1
2021 - 03 - 11
2
2021 - 01 - 28
1
2021 - 01 - 07
1
2020 - 12 - 21
1
2020 - 12 - 08
2
2020 - 12 - 03
1
Crawled Time
00:00
4
01:00
2
03:00
2
04:20
1
06:00
2
07:00
2
08:00
1
09:00
1
10:00
1
11:00
8
12:00
31
12:02
1
12:15
8
12:20
6
12:30
4
13:00
41
13:15
3
13:20
5
13:30
4
13:35
1
13:50
1
14:00
19
14:15
1
14:19
1
14:20
1
14:30
7
15:00
14
15:15
1
15:30
6
16:00
9
16:20
3
17:37
1
18:00
7
18:04
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
19:00
5
20:00
3
20:20
2
20:59
1
21:00
8
22:00
13
23:00
5
Source
investor.alkermes.com
4
www.alnylam.com
26
www.biospace.com
162
www.fda.gov
10
www.globenewswire.com
23
www.prnewswire.com
17
www.vbivaccines.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
Previous years
symbols :
Alny
save search
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-1.06%
|
O:
-1.17%
H:
1.01%
C:
0.11%
first
conference
financial
results
Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session
Published:
2024-03-20
(Crawled : 13:00)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-2.03%
|
O:
-0.11%
H:
0.43%
C:
-0.01%
cardiology
results
study
Rapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directors
Published:
2024-03-19
(Crawled : 15:00)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-1.53%
|
O:
-0.33%
H:
1.88%
C:
0.84%
therapeutics
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
Published:
2024-03-06
(Crawled : 16:00)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-3.02%
|
O:
0.31%
H:
0.06%
C:
-0.33%
biopharma
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published:
2024-03-05
(Crawled : 16:00)
- biospace.com/
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-3.17%
|
O:
1.17%
H:
0.0%
C:
0.0%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-3.25%
|
O:
-0.73%
H:
1.52%
C:
0.5%
positive
blood
care
topline
results
study
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
Published:
2024-03-05
(Crawled : 15:30)
- biospace.com/
VIR
|
$7.96
-3.52%
-3.64%
880K
|
Health Technology
|
-26.27%
|
O:
-0.09%
H:
2.06%
C:
-2.68%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-3.25%
|
O:
-0.73%
H:
1.52%
C:
0.5%
hepatitis
trial
Alnylam to Webcast Presentations at Upcoming March Investor Conferences - February 27, 2024
Published:
2024-02-27
(Crawled : 14:00)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-8.51%
|
O:
0.84%
H:
0.82%
C:
-0.63%
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-22
(Crawled : 00:00)
- biospace.com/
XNCR
|
$18.98
-0.47%
-0.47%
470K
|
Health Technology
|
-20.84%
|
O:
-0.87%
H:
2.89%
C:
2.14%
VIR
|
$7.96
-3.52%
-3.64%
880K
|
Health Technology
|
-18.4%
|
O:
-0.69%
H:
2.99%
C:
2.59%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-6.19%
|
O:
-0.17%
H:
6.18%
C:
5.4%
year
update
financial
results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity
Published:
2024-02-15
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
2.49%
|
O:
1.16%
H:
1.48%
C:
0.89%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.33%
|
O:
1.86%
H:
0.0%
C:
0.0%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-11.57%
|
O:
-8.62%
H:
2.18%
C:
-1.71%
year
pharmaceuticals
financial
results
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-10.14%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-14.28%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published:
2024-02-02
(Crawled : 12:00)
- globenewswire.com
TSVT
|
$4.64
-8.3%
-8.82%
620K
|
|
-2.5%
|
O:
-1.16%
H:
9.94%
C:
2.34%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.09%
|
O:
-0.93%
H:
0.0%
C:
0.0%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
-5.91%
|
O:
1.4%
H:
0.28%
C:
-2.68%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-17.01%
|
O:
-1.23%
H:
1.0%
C:
0.17%
year
financial
results
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-01-29
(Crawled : 14:30)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-19.18%
|
O:
-0.27%
H:
1.32%
C:
1.02%
conference
year
financial
results
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published:
2024-01-22
(Crawled : 22:00)
- prnewswire.com
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
19.0%
|
O:
-0.51%
H:
0.37%
C:
0.32%
MDGL
|
$222.26
-2.66%
-2.8%
220K
|
Health Technology
|
-4.68%
|
O:
1.29%
H:
0.35%
C:
-3.04%
HEPA
|
$2.1118
-0.85%
-1.43%
30K
|
Health Technology
|
0.96%
|
O:
-0.48%
H:
7.69%
C:
1.44%
ALT
|
$6.89
-2.13%
-2.03%
2.7M
|
Commercial Services
|
-31.37%
|
O:
-0.8%
H:
6.02%
C:
0.6%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-21.07%
|
O:
0.46%
H:
3.04%
C:
2.67%
ETNB
|
$8.9
-2.84%
-2.92%
680K
|
Health Technology
|
-13.37%
|
O:
1.19%
H:
0.63%
C:
-0.72%
liver
disease
companies
key
growth
market
Opinion: Brain Health Matters; We Must Not Lose Momentum
Published:
2024-01-08
(Crawled : 07:00)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-23.35%
|
O:
-0.05%
H:
4.12%
C:
3.98%
health
momentum
Alnylam to Webcast Presentation at 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-02
(Crawled : 13:30)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-24.16%
|
O:
-0.8%
H:
3.23%
C:
2.66%
conference
presentation
Alnylam Highlights Significant Progress with Platform Innovation and Clinical Pipeline at R&D Day
Published:
2023-12-13
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-1.13%
|
O:
-0.06%
H:
2.36%
C:
2.36%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-4.01%
|
O:
-0.27%
H:
2.28%
C:
2.16%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-16.52%
|
O:
-0.14%
H:
4.22%
C:
3.97%
day
innovation
pipeline
platform
Alnylam to Webcast Virtual R&D Day - December 6, 2023
Published:
2023-12-06
(Crawled : 14:30)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-14.8%
|
O:
0.37%
H:
3.09%
C:
2.35%
day
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2023
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-11.49%
|
O:
0.93%
H:
2.49%
C:
1.64%
work
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
Published:
2023-11-13
(Crawled : 14:30)
- biospace.com/
VIR
|
$7.96
-3.52%
-3.64%
880K
|
Health Technology
|
-6.14%
|
O:
1.02%
H:
4.5%
C:
3.38%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-10.33%
|
O:
0.04%
H:
1.92%
C:
1.89%
meeting
hepatitis
liver
ongoing
trials
today
Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
Published:
2023-11-10
(Crawled : 15:00)
- biospace.com/
VIR
|
$7.96
-3.52%
-3.64%
880K
|
Health Technology
|
1.35%
|
O:
0.98%
H:
7.06%
C:
6.93%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-11.77%
|
O:
0.49%
H:
0.74%
C:
-2.08%
meeting
hepatitis
liver
ongoing
trials
← Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.